The Food and Drug Administration will hold a virtual Tobacco Products Scientific Advisory Committee (TPSAC) meeting on Jan. 22 to review modified risk tobacco product (MRTP) applications submitted by ...
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that following further review of the supplemental New Drug ...